Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Post by DIYGuyon Jul 27, 2017 7:53pm
122 Views
Post# 26519365

COTI 219

COTI 219With no news we have to believe Phase 1 did not get the results they expected despite the misleading statements in their press releases. I read 70% of phase 1 trials move onto phase 2 but here we are over a year and a half and still have not determined the MTD. The restrictive rules of the FDA seems to only benefit the insiders. If there has been a toxic result we deserve to know when it occurred. 4 weeks after the reverse split we sit twisting in the wind. So, drift to nothing and let the sharks pick up cheap shares on the new PP on the promise of COTI219 or we are done.

The market does not like uncertainty and that is all we have. Should have ran for the hills when Danter resigned. 

How do the big funds like this $1.27. They must be lining up to pick up some shares. What a crock
<< Previous
Bullboard Posts
Next >>